Testosterone deficiency (TD), often referred to as hypogonadism, is associated with aging and affects approximately 30 percent of men ages 40-79. To highlight some of the challenges and controversies encountered in diagnosis and treatment of men with TD, a new review article illustrates the implication of TD on men’s overall health and analyzes a number of studies in men receiving testosterone replacement therapy to treat TD.